Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

Clinical trial NCT03049189 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03049189
Sponsor: ITM Solucin GmbH
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2017-02-02
Primary completion: 2024-11-27
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.